The U.S. Preventive Services Task Force recommends screening high-risk individuals for lung cancer with annual low-dose computed tomography scans. However, in 2024, only about…
New treatment modalities for lung cancer, including targeted therapy and immunotherapy, have contributed to improved patient survival rates. However, these treatments come with unique…
The American Heart Association (AHA) recently held its 2019 Scientific Sessions in Philadelphia PA. The sessions covered many topics, but one of the most…
The U.S. Preventive Services Task Force recommends screening high-risk individuals for lung cancer with annual low-dose computed tomography scans. However, in 2024,…
New treatment modalities for lung cancer, including targeted therapy and immunotherapy, have contributed to improved patient survival rates. However, these treatments come…